Search

Glen E Mikesell

from Fremont, CA
Age ~71
Get Report
Also known as:
Glen Eugene Mikesell, Glenn E Mikesell, Mikesell E Mikesell, Glen E Mickesell
Phone and address:
32622 Lake Arrowhead Ct, Fremont, CA 94555
(609) 433-6369
Related to:
Lacie N Mikesell, 41Yim Y Ko, 67Kitty KoSuk S Ko, 59Yim F Kwok, 84
Connected to:
Allison B Mikesell, 29Andrea B Mikesell, 71Blanca I Mikesell, 56Brian G Mikesell, 56Cassandra L Mikesell, 48Charles B Mikesell, 45Christine E Mikesell, 47Clint A Mikesell, 37Curtis L Mikesell, 69Glen E Mikesell, 65

Glen Mikesell Phones & Addresses

  • 32622 Lake Arrowhead Ct, Fremont, CA 94555 (609) 433-6369
  • 15 Chamberlin Ct, Trenton, NJ 08648 (609) 631-7494
  • 965 Monte Verde Dr, Pacifica, CA 94044 (650) 355-7157
  • Seattle, WA
  • Ashland, KY
  • Alameda, CA
  • San Mateo, CA
  • Belmont, CA
  • 38 Bolton Rd, Hamilton, NJ 08610 (609) 839-0302

Work

Company: Bristol-myers squibb Jun 2013 Address: Redwood City Position: Research associate iv

Education

Degree: Bachelor of Science (BS) School / High School: The Evergreen State College Specialities: Molecular Biology

Emails

g***l@yahoo.com

Industries

Biotechnology

Resumes

Resumes

Glen Mikesell Photo 1

Research Associate Iv At Bristol-Myers Squibb

View page
Position:
Research Associate IV at Bristol-Myers Squibb
Location:
San Francisco Bay Area
Industry:
Biotechnology
Work:
Bristol-Myers Squibb - Redwood City since Jun 2013
Research Associate IV
Teva Pharmaceuticals Mar 2010 - Jun 2013
Research Associate VI
Roche - Palo Alto 2008 - 2009
Research Associate
Raven biotechnologies, inc. - South San Francisco 2003 - 2007
Senior Research Associate
Bristol-Myers Squibb, Princeton, New Jersey - Princeton, NJ 1997 - 2003
Research Scientist
Education:
The Evergreen State College
Bachelor of Science (BS), Molecular Biology

Publications

Us Patents

Polynucleotides-Encoding B7-Related Polypeptide, Bsl2-L165-35B

View page
US Patent:
7279567, Oct 9, 2007
Filed:
Nov 22, 2004
Appl. No.:
10/994824
Inventors:
Glen Eugene Mikesell - Pacifica CA, US
Han Chang - Princeton Junction NJ, US
Robert James Peach - San Diego CA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07H 21/04
C12N 5/10
C12N 1/21
C12N 15/00
C12N 15/11
US Classification:
536 235, 536 231, 536 2353, 435 691, 4353201, 4352523, 435455
Abstract:
The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.

Polynucleotides Encoding Bsl3

View page
US Patent:
7358354, Apr 15, 2008
Filed:
Feb 16, 2006
Appl. No.:
11/355735
Inventors:
Glen Eugene Mikesell - Pacifica CA, US
Han Chang - Princeton Junction NJ, US
Robert James Peach - San Diego CA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07H 21/04
C12N 15/00
C12N 1/21
C12N 5/16
C12P 21/02
US Classification:
536 235, 536 231, 536 234, 536 2353, 4353201, 4352523, 435455, 435 691
Abstract:
The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.

Polynucleotides Encoding Bsl2V1C2-Ig

View page
US Patent:
7368554, May 6, 2008
Filed:
Feb 2, 2006
Appl. No.:
11/346468
Inventors:
Glen E Mikesell - Pacifica CA, US
Han Chang - Princeton Junction NJ, US
Robert James Peach - San Diego CA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07H 21/04
C12N 15/00
C12N 1/21
C12N 5/16
C12N 21/02
US Classification:
536 235, 536 231, 536 234, 536 2353, 4353201, 4352523, 435455, 435 691
Abstract:
The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.

Bsl3 Polypeptides

View page
US Patent:
7723479, May 25, 2010
Filed:
Sep 6, 2007
Appl. No.:
11/900026
Inventors:
Glen Eugene Mikesell - Pacifica CA, US
Han Chang - Princeton Junction NJ, US
Joshua N. Finger - Spring City PA, US
Guchen Yang - Princeton NJ, US
Robert James Peach - San Diego CA, US
Henry Shen - Princeton NJ, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07K 14/705
US Classification:
530350
Abstract:
The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.

Bsl2V1C2 Polypeptides

View page
US Patent:
7807786, Oct 5, 2010
Filed:
Feb 7, 2008
Appl. No.:
12/069064
Inventors:
Glen Eugene Mikesell - Pacifica CA, US
Han Chang - Princeton Junction NJ, US
Robert James Peach - San Diego CA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07K 14/00
US Classification:
530350
Abstract:
The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.

Bsl3 Antibodies

View page
US Patent:
8080636, Dec 20, 2011
Filed:
Feb 5, 2010
Appl. No.:
12/701119
Inventors:
Glen Eugene Mikesell - Pacifica CA, US
Han Chang - Princeton Junction NJ, US
Robert James Peach - San Diego CA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07K 16/00
US Classification:
5303871
Abstract:
The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.

Polynucleotides Encoding Bsl2Vcvc-Lg

View page
US Patent:
8354513, Jan 15, 2013
Filed:
May 20, 2010
Appl. No.:
12/783968
Inventors:
Glen Eugene Mikesell - Pacifica CA, US
Han Chang - Princeton Junction NJ, US
Robert James Peach - San Diego CA, US
Assignee:
Bristol-Myers Squibb Company - Princeton NJ
International Classification:
C07H 21/04
US Classification:
536 231
Abstract:
The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.

B7-Related Nucleic Acids And Polypeptides Useful For Immunomodulation

View page
US Patent:
20020095024, Jul 18, 2002
Filed:
Jun 6, 2001
Appl. No.:
09/875338
Inventors:
Glen Mikesell - Hamilton NJ, US
Han Chang - Princeton Junction NJ, US
Joshua Finger - San Marcos CA, US
Guchen Yang - Morrisvill PA, US
Pin Lu - Cherry Hill NJ, US
Robert Peach - San Diego CA, US
International Classification:
C07K014/705
C07K016/28
C12P021/02
C07H021/04
C12N005/06
US Classification:
530/350000, 530/388220, 536/023500, 435/069100, 435/320100, 435/325000
Abstract:
The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.
Control profile
Glen E Mikesell from Fremont, CA, age ~71 Get Report